Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Captopril.
Abiraterone
The serum concentration of Captopril can be increased when it is combined with Abiraterone.
Acebutolol
Acebutolol may increase the hypotensive activities of Captopril.
Advertisement
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Captopril.
Acemetacin
The therapeutic efficacy of Captopril can be decreased when used in combination with Acemetacin.
Acetyl salicylate
The therapeutic efficacy of Captopril can be decreased when used in combination with Acetylsalicylic acid.
Advertisement
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Captopril.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Captopril.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Captopril.
Advertisement
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Captopril.
Aliskiren
Aliskiren may increase the hypotensive, nephrotoxic, and hyperkalemic activities of Captopril.
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Captopril.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Captopril.
Alogliptin
The risk or severity of adverse effects can be increased when Alogliptin is combined with Captopril.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aloxiprin
The therapeutic efficacy of Captopril can be decreased when used in combination with Aloxiprin.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Captopril.
Alprenolol
Alprenolol may increase the hypotensive activities of Captopril.
Aluminum
Aluminium can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ambrisentan
Captopril may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Captopril.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Captopril.
Amifostine
Captopril may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Captopril may increase the hypotensive activities of Amifostine.
Amiloride
Amiloride may increase the hyperkalemic activities of Captopril.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Captopril.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Captopril.
Aminosalicylic Acid
The therapeutic efficacy of Captopril can be decreased when used in combination with Aminosalicylic Acid.
Amiodarone
The metabolism of Captopril can be decreased when combined with Amiodarone.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Captopril.
Amlodipine
Amlodipine may increase the hypotensive activities of Captopril.
Amobarbital
Amobarbital may increase the hypotensive activities of Captopril.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Captopril.
Amphetamine
Amphetamine may increase the hypotensive activities of Captopril.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Captopril.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Captopril.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Captopril is combined with Amyl Nitrite.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Captopril.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Captopril.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Captopril.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Captopril.
Apraclonidine
The risk or severity of adverse effects can be increased when Apraclonidine is combined with Captopril.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Captopril.
Aprotinin
Aprotinin may decrease the antihypertensive activities of Captopril.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Captopril.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Captopril.
Artemether
The metabolism of Captopril can be decreased when combined with Artemether.
Aspirin
The therapeutic efficacy of Captopril can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Captopril.
Atomoxetine
The metabolism of Captopril can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Atorvastatin is combined with Captopril.
Avanafil
Avanafil may increase the antihypertensive activities of Captopril.
Azathioprine
The risk or severity of anemia and severe leukopenia can be increased when Captopril is combined with Azathioprine.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Captopril.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Captopril.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Captopril.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Captopril.
Azosemide
Azosemide may increase the hypotensive activities of Captopril.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Captopril.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Captopril.
Barbital
Barbital may increase the hypotensive activities of Captopril.
Benazepril
Benazepril may increase the hypotensive activities of Captopril.
Bendroflumethiazide
The risk or severity of hypotension can be increased when Bendroflumethiazide is combined with Captopril.
Benzthiazide
The risk or severity of hypotension can be increased when Benzthiazide is combined with Captopril.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Captopril.
Bepridil
Captopril may increase the hypotensive activities of Bepridil.
Betaxolol
The metabolism of Captopril can be decreased when combined with Betaxolol.
Bethanidine
Bethanidine may increase the hypotensive activities of Captopril.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Captopril.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Captopril.
Boceprevir
The serum concentration of Captopril can be decreased when it is combined with Boceprevir.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Captopril.
Bosentan
Bosentan may increase the hypotensive activities of Captopril.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Captopril.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Captopril.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Captopril.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Captopril.
Bretylium
Bretylium may increase the hypotensive activities of Captopril.
Brimonidine
Brimonidine may increase the antihypertensive activities of Captopril.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Captopril.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Captopril.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Captopril.
Bumetanide
Bumetanide may increase the hypotensive activities of Captopril.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Captopril.
Bupranolol
Captopril may increase the hypotensive activities of Bupranolol.
Bupropion
The metabolism of Captopril can be decreased when combined with Bupropion.
Butriptyline
The serum concentration of Butriptyline can be increased when it is combined with Captopril.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Captopril.
Cafedrine
Captopril may increase the hypotensive activities of Cafedrine.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Canagliflozin
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Captopril.
Canagliflozin Anhydrous
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Captopril.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Captopril.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Captopril.
Carbamazepine
The metabolism of Captopril can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Captopril.
Carteolol
Carteolol may increase the hypotensive activities of Captopril.
Carvedilol
Carvedilol may increase the hypotensive activities of Captopril.
Celecoxib
The metabolism of Captopril can be decreased when combined with Celecoxib.
Celiprolol
Captopril may increase the hypotensive activities of Celiprolol.
Chloroquine
The metabolism of Captopril can be decreased when combined with Chloroquine.
Chlorothiazide
The risk or severity of hypotension can be increased when Chlorothiazide is combined with Captopril.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Captopril.
Chlorpromazine
The metabolism of Captopril can be decreased when combined with Chlorpromazine.
Chlorthalidone
The risk or severity of hypotension can be increased when Chlorthalidone is combined with Captopril.
Cholecalciferol
The metabolism of Captopril can be decreased when combined with Cholecalciferol.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Captopril.
Cicletanine
Captopril may increase the hypotensive activities of Cicletanine.
Cilazapril
Captopril may increase the hypotensive activities of Cilazapril.
Cimetidine
The metabolism of Captopril can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Captopril can be decreased when combined with Cinacalcet.
Ciprofloxacin
The risk or severity of ventricular arrhythmias can be increased when Captopril is combined with Ciprofloxacin.
Citalopram
The metabolism of Captopril can be decreased when combined with Citalopram.
Clarithromycin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Captopril.
Clemastine
The metabolism of Captopril can be decreased when combined with Clemastine.
Clevidipine
The risk or severity of adverse effects can be increased when Captopril is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Captopril is combined with Clevidipine.
Clobazam
The metabolism of Captopril can be decreased when combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Captopril.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Captopril.
Clonidine
Clonidine may increase the hypotensive activities of Captopril.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Captopril.
Clotrimazole
The metabolism of Captopril can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Captopril can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Captopril can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Captopril can be decreased when combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Captopril.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Captopril.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Captopril.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Captopril.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be increased when it is combined with Captopril.
Cyclopenthiazide
The risk or severity of hypotension can be increased when Cyclopenthiazide is combined with Captopril.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Captopril is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Captopril is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Captopril.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Captopril.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Captopril.
Dapagliflozin
The risk or severity of adverse effects can be increased when Captopril is combined with Dapagliflozin.
Darifenacin
The metabolism of Captopril can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Captopril can be increased when it is combined with Darunavir.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Captopril.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Captopril.
Deserpidine
Captopril may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Captopril.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Captopril.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Captopril.
Diazoxide
Diazoxide may increase the hypotensive activities of Captopril.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Captopril.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Captopril.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Captopril.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Captopril.
Diflunisal
The therapeutic efficacy of Captopril can be decreased when used in combination with Diflunisal.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Captopril.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Captopril.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be increased when it is combined with Captopril.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Captopril.
Dinutuximab
The risk or severity of adverse effects can be increased when Captopril is combined with Dinutuximab.
Diphenhydramine
The metabolism of Captopril can be decreased when combined with Diphenhydramine.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Captopril.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Captopril.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Captopril.
Dothiepin
The metabolism of Captopril can be decreased when combined with Dosulepin.
Doxazosin
Doxazosin may increase the hypotensive activities of Captopril.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Captopril.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Captopril.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Captopril.
Dronedarone
The metabolism of Captopril can be decreased when combined with Dronedarone.
Drospirenone
Captopril may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Captopril.
Duloxetine
Captopril may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Captopril.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Captopril.
Eliglustat
The metabolism of Captopril can be decreased when combined with Eliglustat.
Empagliflozin
The risk or severity of adverse effects can be increased when Captopril is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Captopril.
Enalaprilat
Captopril may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Captopril may increase the hypotensive activities of Enalaprilat.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Captopril.
Eplerenone
Eplerenone may increase the hyperkalemic activities of Captopril.
Epoprostenol
Captopril may increase the hypotensive activities of Epoprostenol.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Captopril.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Captopril.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Captopril.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Captopril.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Captopril.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Captopril.
Estradiol Cypionate
The serum concentration of Estradiol cypionate can be decreased when it is combined with Captopril.
Estradiol Valerate
The serum concentration of Estradiol valerate can be decreased when it is combined with Captopril.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Captopril.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Captopril.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Captopril.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Captopril.
Ethacrynate
Etacrynic acid may increase the hypotensive activities of Captopril.
Ethacrynic Acid
Etacrynic acid may increase the hypotensive activities of Captopril.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Captopril.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Captopril.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Captopril.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Captopril.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Captopril.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Captopril.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Captopril.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Captopril.
Felodipine
Felodipine may increase the hypotensive activities of Captopril.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Captopril.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Captopril.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Captopril.
Ferulic Acid
Captopril may increase the hypotensive activities of Ferulic acid.
Fibrinolysis Inhibitor
Aprotinin may decrease the antihypertensive activities of Captopril.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Captopril.
Fluoxetine
The metabolism of Captopril can be decreased when combined with Fluoxetine.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Captopril.
Fluvoxamine
The metabolism of Captopril can be decreased when combined with Fluvoxamine.
Fosinopril
Fosinopril may increase the hypotensive activities of Captopril.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Captopril.
Furazolidone
Furazolidone may increase the hypotensive activities of Captopril.
Furosemide
Furosemide may increase the hypotensive activities of Captopril.
Garlic Allergenic Extract
The serum concentration of Captopril can be decreased when it is combined with Garlic.
Gold Sodium Thiomalate
The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Captopril is combined with Sodium aurothiomalate.
Guanabenz
Guanabenz may increase the hypotensive activities of Captopril.
Guanadrel
Guanadrel may increase the hypotensive activities of Captopril.
Guanethidine
Guanethidine may increase the hypotensive activities of Captopril.
Guanfacine
Guanfacine may increase the hypotensive activities of Captopril.
Haloperidol
The metabolism of Captopril can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Captopril.
Heparin
The risk or severity of hyperkalemia can be increased when Captopril is combined with Heparin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Captopril.
Hydralazine
Hydralazine may increase the hypotensive activities of Captopril.
Hydrochlorothiazide
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Captopril.
Hydroflumethiazide
The risk or severity of hypotension can be increased when Hydroflumethiazide is combined with Captopril.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hypoxis hemerocallidea root extract
The metabolism of Captopril can be increased when combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Captopril.
Icatibant
Icatibant may decrease the antihypertensive activities of Captopril.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Captopril.
Imidapril
Captopril may increase the hypotensive activities of Imidapril.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Captopril.
Indapamide
The risk or severity of hypotension can be increased when Indapamide is combined with Captopril.
Indinavir
The metabolism of Captopril can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Captopril can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Captopril.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Captopril.
Indoramin
Indoramin may increase the hypotensive activities of Captopril.
Iproniazid
Iproniazid may increase the hypotensive activities of Captopril.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Captopril.
Iron
Iron can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Iron can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
The risk or severity of adverse effects can be increased when Captopril is combined with Iron Dextran.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Captopril.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Captopril.
Isoniazid
The metabolism of Captopril can be decreased when combined with Isoniazid.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Captopril.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Captopril.
Isoxsuprine
The risk or severity of adverse effects can be increased when Captopril is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Captopril.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Captopril.
Ketanserin
Ketanserin may increase the hypotensive activities of Captopril.
Ketoconazole
The metabolism of Captopril can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Captopril.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Captopril.
Labetalol
Labetalol may increase the hypotensive activities of Captopril.
Lacidipine
Captopril may increase the hypotensive activities of Lacidipine.
Lanthanum Carbonate
The serum concentration of Captopril can be decreased when it is combined with Lanthanum carbonate.
Latanoprost
Latanoprost may increase the hypotensive activities of Captopril.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Captopril.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Captopril.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Captopril.
Levobunolol
The risk or severity of adverse effects can be increased when Captopril is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Captopril.
Levodopa
Captopril may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Captopril.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Captopril.
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Captopril.
Lisinopril
Lisinopril may increase the hypotensive activities of Captopril.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Captopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Captopril.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Captopril.
Lofexidine
Captopril may increase the hypotensive activities of Lofexidine.
Lopinavir
The metabolism of Captopril can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Captopril can be decreased when combined with Lorcaserin.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Captopril.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Captopril.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Captopril.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Captopril.
Lumefantrine
The metabolism of Captopril can be decreased when combined with Lumefantrine.
Macitentan
Captopril may increase the hypotensive activities of Macitentan.
Magaldrate
Magaldrate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Captopril.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Manidipine
Captopril may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Captopril.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Captopril.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Captopril.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Captopril.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Captopril.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Captopril.
MELITRACEN
The serum concentration of Melitracen can be increased when it is combined with Captopril.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Captopril.
Meperidine
The risk or severity of adverse effects can be increased when Captopril is combined with Pethidine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Captopril.
Mepirodipine
Captopril may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Captopril can be decreased when used in combination with Mesalazine.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Captopril.
Methadone
The metabolism of Captopril can be decreased when combined with Methadone.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Captopril.
Methohexital
Methohexital may increase the hypotensive activities of Captopril.
Methotrimeprazine
The metabolism of Captopril can be decreased when combined with Methotrimeprazine.
Methyclothiazide
The risk or severity of hypotension can be increased when Methyclothiazide is combined with Captopril.
Methyl Salicylate
The therapeutic efficacy of Captopril can be decreased when used in combination with Methyl salicylate.
Methyldopa
Methyldopa may increase the hypotensive activities of Captopril.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Captopril.
Methylene blue
Methylene blue may increase the hypotensive activities of Captopril.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Captopril.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Captopril.
Metipranolol
Captopril may increase the hypotensive activities of Metipranolol.
Metolazone
The risk or severity of hypotension can be increased when Metolazone is combined with Captopril.
Metoprolol
The metabolism of Captopril can be decreased when combined with Metoprolol.
Metyrosine
Captopril may increase the hypotensive activities of Metyrosine.
Mibefradil
Captopril may increase the hypotensive activities of Mibefradil.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Captopril.
Midostaurin
The metabolism of Captopril can be decreased when combined with Midostaurin.
Minaprine
Minaprine may increase the hypotensive activities of Captopril.
Minoxidil
Minoxidil may increase the hypotensive activities of Captopril.
Mirabegron
The metabolism of Captopril can be decreased when combined with Mirabegron.
Mirtazapine
The serum concentration of Mirtazapine can be increased when it is combined with Captopril.
Moclobemide
Moclobemide may increase the hypotensive activities of Captopril.
Moexipril
Moexipril may increase the hypotensive activities of Captopril.
Molsidomine
Molsidomine may increase the hypotensive activities of Captopril.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Captopril.
Moxonidine
Moxonidine may increase the hypotensive activities of Captopril.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Captopril.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Captopril.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Captopril.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Captopril.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Captopril.
Nadolol
Captopril may increase the hypotensive activities of Nadolol.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Captopril.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Captopril.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Captopril.
Nebivolol
Captopril may increase the hypotensive activities of Nebivolol.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Captopril.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Captopril.
Nesiritide
The risk or severity of adverse effects can be increased when Captopril is combined with Nesiritide.
Nevirapine
The metabolism of Captopril can be decreased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Captopril.
Nicardipine
The metabolism of Captopril can be decreased when combined with Nicardipine.
Nicorandil
Nicorandil may increase the vasodilatory activities of Captopril.
Nifedipine
The risk or severity of adverse effects can be increased when Nifedipine is combined with Captopril.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Captopril.
Nilotinib
The metabolism of Captopril can be decreased when combined with Nilotinib.
Nilvadipine
Captopril may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Captopril.
Nimodipine
Nimodipine may increase the hypotensive activities of Captopril.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Captopril.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Captopril.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Captopril.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Captopril.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Captopril.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Captopril.
Obinutuzumab
Captopril may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Captopril.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Captopril.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Captopril.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Captopril.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Captopril.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Captopril.
Oxprenolol
Captopril may increase the hypotensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Captopril.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Captopril.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Captopril.
Panobinostat
The serum concentration of Captopril can be increased when it is combined with Panobinostat.
Papaverine
The risk or severity of adverse effects can be increased when Papaverine is combined with Captopril.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Captopril.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Captopril.
Pargyline
Pargyline may increase the hypotensive activities of Captopril.
Paroxetine
The metabolism of Captopril can be decreased when combined with Paroxetine.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Captopril.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Captopril.
Peginterferon Alfa-2b
The serum concentration of Captopril can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Captopril may increase the hypotensive activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Captopril.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Captopril.
Perindopril
Perindopril may increase the hypotensive activities of Captopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Captopril.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Captopril.
Phenoxybenzamine
Phenoxybenzamine may increase the hypotensive activities of Captopril.
Phentolamine
Phentolamine may increase the hypotensive activities of Captopril.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Captopril.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Captopril.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Captopril.
Pinacidil
Pinacidil may increase the hypotensive activities of Captopril.
Pindolol
Pindolol may increase the hypotensive activities of Captopril.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Captopril.
Piretanide
Piretanide may increase the hypotensive activities of Captopril.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Captopril.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Captopril.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Captopril.
Polythiazide
The risk or severity of hypotension can be increased when Polythiazide is combined with Captopril.
Potassium
Potassium may increase the hyperkalemic activities of Captopril.
Potassium Bicarbonate
Potassium bicarbonate may increase the hyperkalemic activities of Captopril.
Potassium Chloride
Potassium Chloride may increase the hyperkalemic activities of Captopril.
Potassium Citrate
Potassium Citrate may increase the hyperkalemic activities of Captopril.
Potassium Ion
Potassium may increase the hyperkalemic activities of Captopril.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Captopril.
Prazosin
Prazosin may increase the hypotensive activities of Captopril.
Pregabalin
The risk or severity of angioedema can be increased when Captopril is combined with Pregabalin.
Primidone
Primidone may increase the hypotensive activities of Captopril.
Procaine
Procaine may increase the hypotensive activities of Captopril.
Procarbazine
Procarbazine may increase the hypotensive activities of Captopril.
Promazine
The metabolism of Captopril can be decreased when combined with Promazine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Captopril.
Propranolol
Propranolol may increase the hypotensive activities of Captopril.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Captopril.
Quetiapine
The risk or severity of adverse effects can be increased when Captopril is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Captopril is combined with Quetiapine.
Quinapril
Quinapril may increase the hypotensive activities of Captopril.
Quinethazone
The risk or severity of hypotension can be increased when Quinethazone is combined with Captopril.
Quinidine
The metabolism of Captopril can be decreased when combined with Quinidine.
Quinine
The metabolism of Captopril can be decreased when combined with Quinine.
Ramipril
Ramipril may increase the hypotensive activities of Captopril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Captopril.
Rasagiline
Rasagiline may increase the hypotensive activities of Captopril.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Captopril.
Rescinnamine
Captopril may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Captopril.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Captopril.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Captopril.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Captopril.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Captopril.
Risperidone
Captopril may increase the hypotensive activities of Risperidone.
Ritonavir
The metabolism of Captopril can be decreased when combined with Ritonavir.
Rituximab
Captopril may increase the hypotensive activities of Rituximab.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Captopril.
Rolapitant
The metabolism of Captopril can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Captopril can be decreased when combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Captopril.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Captopril.
Rucaparib
The metabolism of Captopril can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of angioedema can be increased when Captopril is combined with Sacubitril.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Captopril.
Salicylic Acid
The therapeutic efficacy of Captopril can be decreased when used in combination with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Captopril.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Captopril.
Saxagliptin
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Captopril.
Saxagliptin Anhydrous
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Captopril.
Secobarbital
Secobarbital may increase the hypotensive activities of Captopril.
Selegiline
Selegiline may increase the hypotensive activities of Captopril.
Selexipag
Captopril may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Captopril.
Sertraline
The metabolism of Captopril can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Captopril.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Captopril.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Captopril.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Captopril.
Sirolimus
The risk or severity of angioedema can be increased when Sirolimus is combined with Captopril.
Sitagliptin
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Captopril.
Sitagliptin Phosphate
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Captopril.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Captopril may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Captopril may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Captopril may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Captopril.
Spirapril
Captopril may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.
ST. JOHN'S WORT EXTRACT
The metabolism of Captopril can be increased when combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Captopril.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Captopril.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Captopril.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Captopril.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Captopril.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Captopril.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Captopril.
Tadalafil
Tadalafil may increase the antihypertensive activities of Captopril.
Talinolol
Captopril may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Captopril.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Captopril.
Temsirolimus
The risk or severity of adverse effects can be increased when Captopril is combined with Temsirolimus.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Captopril.
Terazosin
The risk or severity of adverse effects can be increased when Terazosin is combined with Captopril.
Terbinafine
The metabolism of Captopril can be decreased when combined with Terbinafine.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Captopril.
Terlipressin
Captopril may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Captopril.
Theodrenaline
Captopril may increase the hypotensive activities of Theodrenaline.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Captopril.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Captopril.
Thiamylal
Thiamylal may increase the hypotensive activities of Captopril.
Thiopental
Thiopental may increase the hypotensive activities of Captopril.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Captopril.
Thioridazine
The metabolism of Captopril can be decreased when combined with Thioridazine.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Captopril.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Captopril.
Tibolone
Captopril may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Captopril can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypotensive activities of Captopril.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Captopril.
Tipranavir
The serum concentration of Captopril can be decreased when it is combined with Tipranavir.
Tizanidine
The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.
Tolazoline
Tolazoline may increase the hypotensive activities of Captopril.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Captopril.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Captopril.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Captopril.
Toloxatone
Toloxatone may increase the hypotensive activities of Captopril.
Tolvaptan
Tolvaptan may increase the hyperkalemic activities of Captopril.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Captopril.
Torsemide
Torasemide may increase the hypotensive activities of Captopril.
Trandolapril
Trandolapril may increase the hypotensive activities of Captopril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Captopril.
Tranylcypromine
The metabolism of Captopril can be decreased when combined with Tranylcypromine.
Travoprost
Travoprost may increase the hypotensive activities of Captopril.
Treprostinil
Treprostinil may increase the hypotensive activities of Captopril.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Captopril.
Triamterene
Triamterene may increase the hyperkalemic activities of Captopril.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Captopril.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Captopril.
Trichlormethiazide
The risk or severity of hypotension can be increased when Trichlormethiazide is combined with Captopril.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Captopril.
Trimethoprim
Trimethoprim may increase the hyperkalemic activities of Captopril.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Captopril.
Trolamine Salicylate
The therapeutic efficacy of Captopril can be decreased when used in combination with Trolamine salicylate.
Tromethamine
Tromethamine can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
UNOPROSTONE
Captopril may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Captopril.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Captopril.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Captopril.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Captopril.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Captopril.
Vardenafil
Vardenafil may increase the antihypertensive activities of Captopril.
Venlafaxine
The metabolism of Captopril can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Verapamil can be decreased when combined with Captopril.
Vildagliptin
The risk or severity of adverse effects can be increased when Vildagliptin is combined with Captopril.
Vincamine
Captopril may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Captopril.
Vinpocetine
Captopril may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Captopril may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Captopril.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Captopril.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Captopril.
Ziprasidone
The metabolism of Captopril can be decreased when combined with Ziprasidone.
Zofenopril
Captopril may increase the hypotensive activities of Zofenopril.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Captopril.
